GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Aion Therapeutic Inc (XCNQ:AION) » Definitions » Shares Buyback Ratio %

Aion Therapeutic (XCNQ:AION) Shares Buyback Ratio % : -179.40 (As of Jun. 12, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Aion Therapeutic Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Aion Therapeutic's current shares buyback ratio was -179.40%.


Aion Therapeutic Shares Buyback Ratio % Historical Data

The historical data trend for Aion Therapeutic's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Aion Therapeutic Shares Buyback Ratio % Chart

Aion Therapeutic Annual Data
Trend Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23
Shares Buyback Ratio %
Get a 7-Day Free Trial - -5.80 -240.24 -13.62 -3.88

Aion Therapeutic Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Shares Buyback Ratio % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - -43.62 -94.54

Aion Therapeutic Shares Buyback Ratio % Calculation

Aion Therapeutic's Shares Buyback Ratio for the fiscal year that ended in Apr. 2023 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Apr. 2022 ) - Shares Outstanding (EOP) (A: Apr. 2023 )) / Shares Outstanding (EOP) (A: Apr. 2022 )
=(141.799 - 147.299) / 141.799
=-3.88%

Aion Therapeutic's Shares Buyback Ratio for the quarter that ended in Jan. 2024 is calculated as

Shares Buyback Ratio=(Shares Outstanding (EOP) (A: Oct. 2023 ) - Shares Outstanding (EOP) (A: Jan. 2024 )) / Shares Outstanding (EOP) (A: Oct. 2023 )
=(211.549 - 411.549) / 211.549
=-94.54%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Aion Therapeutic Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Aion Therapeutic's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.


Aion Therapeutic (XCNQ:AION) Business Description

Traded in Other Exchanges
Address
700 West Georgia Street, Suite 2200, Vancouver, BC, CAN, V7Y 1K8
Aion Therapeutic Inc is in the business of research and development, treatment, data mining, and state of the art artificial intelligence techniques, focused on the development of combinatorial pharmaceuticals, nutraceuticals, and cosmeceuticals utilizing compounds from cannabis, psychedelic mushrooms, fungi, natural psychedelic formulations, and other medicinal plants in a legal environment for this type of discovery.
Executives
Ismail Abdul Fattah Director or Senior Officer of 10% Security Holder

Aion Therapeutic (XCNQ:AION) Headlines

No Headlines